Research outputs
2025
Contributors to organ damage in childhood lupus: corticosteroid use and disease activity
Hanif, M., Sarker, C., Al-Abadi, E., Armon, K., Bailey, K., Bohm, M., . . . Smith, E. M. D. (2025). Contributors to organ damage in childhood lupus: corticosteroid use and disease activity. RHEUMATOLOGY, 64(5). doi:10.1093/rheumatology/keae592
Relative Contribution of Pharmacokinetics and Immune Signatures to Clinical Outcomes in Patients With HIV-associated Cryptococcal Meningitis
Stott, K. E., Tembo, D., Kajanga, C., Ahmadu, A., Namakhwa, D., Kolamunnage-Dona, R., . . . Mwandumba, H. C. (2025). Relative Contribution of Pharmacokinetics and Immune Signatures to Clinical Outcomes in Patients With HIV-associated Cryptococcal Meningitis. OPEN FORUM INFECTIOUS DISEASES, 12(4). doi:10.1093/ofid/ofaf190
2024
EVALUATING CHILDHOOD LUPUS LOW DISEASE ACTIVITY STATE (cLLDAS) AS A POTENTIAL TREAT-TO-TARGET TREATMENT ENDPOINT: A VALIDATION AND SENSITIVITY ANALYSIS
Smith, E. M., Sarker, C., Jorgensen, A. L., Beresford, M. W., & UK, J. C. S. (2024). EVALUATING CHILDHOOD LUPUS LOW DISEASE ACTIVITY STATE (cLLDAS) AS A POTENTIAL TREAT-TO-TARGET TREATMENT ENDPOINT: A VALIDATION AND SENSITIVITY ANALYSIS. In ANNALS OF THE RHEUMATIC DISEASES Vol. 83. doi:10.1136/annrheumdis-2024-eular.5896
EVALUATING THE IMPACT OF CHILDHOOD-ONSET SYSTEMIC LUPUS ERYTHEMATOSUS T2T TARGET ATTAINMENT: MITIGATING FLARES AND NEW DAMAGE ACCRUAL
Sarker, C., Jorgensen, A. L., Beresford, M. W., & Smith, E. M. D. (2024). EVALUATING THE IMPACT OF CHILDHOOD-ONSET SYSTEMIC LUPUS ERYTHEMATOSUS T2T TARGET ATTAINMENT: MITIGATING FLARES AND NEW DAMAGE ACCRUAL. In ANNALS OF THE RHEUMATIC DISEASES Vol. 83. doi:10.1136/annrheumdis-2024-eular.697
FACTORS ASSOCIATED WITH DAMAGE ACCRUAL IN CHILDHOOD SYSTEMIC LUPUS ERYTHEMATOSUS (cSLE): CORTICOSTEROID REGIMENS AND MAINTENANCE OF LOW DISEASE ACTIVITY
Hanif, M., Sarker, C., Beresford, M. W., & Smith, E. M. (2024). FACTORS ASSOCIATED WITH DAMAGE ACCRUAL IN CHILDHOOD SYSTEMIC LUPUS ERYTHEMATOSUS (cSLE): CORTICOSTEROID REGIMENS AND MAINTENANCE OF LOW DISEASE ACTIVITY. In ANNALS OF THE RHEUMATIC DISEASES Vol. 83 (pp. 227-228). doi:10.1136/annrheumdis-2024-eular.1166